Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias May

Showing results (211-220 of 278) with videos related to

Pageof 28
Sort By:
Urologia Internationalis|August 21, 2014
The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Maximilian Burger, et al.
Acta Anaesthesiologica Scandinavica|April 24, 2019
Rational application of antibiotics-The influence of anaesthetists' gender on self-confidence and knowledgeMarkus Heim, Frederick Schneider, Haitham Mutlak, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> Achievement. <i>Curr. Oncol.</i> 2023, <i>30</i>, 1882-1892Matthias May, Steffen Lebentrau, Ben Ayres, et al.
Caspian Journal of Internal Medicine|August 1, 2019
Awareness and perception of multidrug-resistant organisms and antimicrobial therapy among internists vs. surgeons of different specialties: Results from the German MR2 SurveyPhilipp J Spachmann, Matthias May, Malte W Vetterlein, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Aktuelle Urologie|June 20, 2023
[Initial presentation of the Pentafecta score as a quality instrument for outcome evaluation of primary surgical treatment in patients with penile cancer]Matthias May, Steffen Lebentrau, Nick Watkin, et al.
Cancers|February 24, 2024
Urine-Based Biomarker Test Uromonitor<sup>®</sup> in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test PerformanceAnton P Kravchuk, Ingmar Wolff, Christian Gilfrich, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Diagnostic Performance and Clinical Utility of the Uromonitor<sup>®</sup> Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-AnalysisJulio Ruben Rodas Garzaro, Anton Kravchuk, Maximilian Burger, et al.
European Radiology|July 31, 2021
Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumorsJohannes Uhlig, Annemarie Uhlig, Sophie Bachanek, et al.
Pageof 28

Showing results (211-220 of 278) with videos related to

Sort By:
Pageof 28
Urologia Internationalis|August 21, 2014
The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladderRoman Mayr, Matthias May, Maximilian Burger, et al.
Acta Anaesthesiologica Scandinavica|April 24, 2019
Rational application of antibiotics-The influence of anaesthetists' gender on self-confidence and knowledgeMarkus Heim, Frederick Schneider, Haitham Mutlak, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
The Goal of Achieving High-Quality Surgical First-Line Therapy in Patients with Penile Cancer Is Important; However, Some Collective Efforts Are Still Required in Order to Reach It. Comment on Brassetti et al. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> Achievement. <i>Curr. Oncol.</i> 2023, <i>30</i>, 1882-1892Matthias May, Steffen Lebentrau, Ben Ayres, et al.
Caspian Journal of Internal Medicine|August 1, 2019
Awareness and perception of multidrug-resistant organisms and antimicrobial therapy among internists vs. surgeons of different specialties: Results from the German MR2 SurveyPhilipp J Spachmann, Matthias May, Malte W Vetterlein, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Aktuelle Urologie|June 20, 2023
[Initial presentation of the Pentafecta score as a quality instrument for outcome evaluation of primary surgical treatment in patients with penile cancer]Matthias May, Steffen Lebentrau, Nick Watkin, et al.
Cancers|February 24, 2024
Urine-Based Biomarker Test Uromonitor<sup>®</sup> in the Detection and Disease Monitoring of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of Diagnostic Test PerformanceAnton P Kravchuk, Ingmar Wolff, Christian Gilfrich, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
Diagnostics (Basel, Switzerland)|January 28, 2026
Diagnostic Performance and Clinical Utility of the Uromonitor<sup>®</sup> Molecular Urine Assay for Urothelial Carcinoma of the Bladder: A Systematic Review and Diagnostic Accuracy Meta-AnalysisJulio Ruben Rodas Garzaro, Anton Kravchuk, Maximilian Burger, et al.
European Radiology|July 31, 2021
Primary renal sarcomas: imaging features and discrimination from non-sarcoma renal tumorsJohannes Uhlig, Annemarie Uhlig, Sophie Bachanek, et al.
Pageof 28